Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.
Curr Diab Rep
; 16(12): 122, 2016 12.
Article
em En
| MEDLINE
| ID: mdl-27766582
ABSTRACT
The prevalence of diabetes is growing at epidemic rates in the USA. Diabetic retinopathy develops in a large proportion of patients and is a leading cause of blindness worldwide. Systemic management of diabetic retinopathy has included glycemic, hypertension, and lipid control. Local ophthalmic treatment in the form of focal/grid or panretinal laser photocoagulation has been shown to prevent vision loss in diabetic edema and proliferative diabetic retinopathy, respectively. The introduction of anti-vascular endothelial growth factor for diabetic macular edema and retinopathy has provided clinicians with improved clinical outcomes with potentially less damaging effects than laser.
Palavras-chave
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Fator A de Crescimento do Endotélio Vascular
/
Retinopatia Diabética
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Curr Diab Rep
Assunto da revista:
ENDOCRINOLOGIA
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Estados Unidos